-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AFtuVM7dwaI22+RLHl5SA/yWjFmXBg+6BtfdlPADH1FYi5fP9InvOA6M8JBzYPEx 3YJL4xYGC3GYT8ZRSw0L1g== 0001169232-03-001447.txt : 20030218 0001169232-03-001447.hdr.sgml : 20030217 20030218171807 ACCESSION NUMBER: 0001169232-03-001447 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030218 GROUP MEMBERS: ORION BIOMEDICAL FUND, L.P. FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ORION BIOMEDICAL GP LLC CENTRAL INDEX KEY: 0001158330 IRS NUMBER: 134159153 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 787 7TH AVE., 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125544345 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CARDIMA INC CENTRAL INDEX KEY: 0001022570 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 943177883 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-52701 FILM NUMBER: 03571504 BUSINESS ADDRESS: STREET 1: 47266 BENICIA STREET CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 5103540300 MAIL ADDRESS: STREET 1: 47266 BENICIA ST CITY: FREMONT STATE: CA ZIP: 94538 SC 13G/A 1 d53940_sc13ga.txt AMENDMENT NO. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A (Amendment No. 2) Under the Securities Exchange Act of 1934 Cardima, Inc. Common Stock, par value $.001 per share (Title of Class of Securities) February 14, 2003 (CUSIP Number: 14147M106) Date of event which requires filing December 31, 2002 Check the appropriate box to designate the rule pursuant to which the schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filled for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes to Schedule 13G). 1 - ------------------- ----------------- CUSIP No. 14147M106 13G Page 2 of 5 Pages - ------------------- ----------------- - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Orion Biomedical GP, LLC. - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES None ----------------------------------------------------------------- BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 620,056 ----------------------------------------------------------------- EACH 7. SOLE DISPOSITIVE POWER REPORTING None ----------------------------------------------------------------- PERSON 8. SHARED DISPOSITIVE POWER WITH 620,056 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 620,056 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.2% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* OO (Limited Liability Company) - -------------------------------------------------------------------------------- 2 - ------------------- ----------------- CUSIP No. 14147M106 13G Page 3 of 5 Pages - ------------------- ----------------- - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Orion Biomedical Fund, L.P.. - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES None ----------------------------------------------------------------- BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 445,056 ----------------------------------------------------------------- EACH 7. SOLE DISPOSITIVE POWER REPORTING None ----------------------------------------------------------------- PERSON 8. SHARED DISPOSITIVE POWER WITH 445,056 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 445,056 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.9% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- 3 ITEM 1(a). NAME OF ISSUER: Cardima, Inc. (the "Company") ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 47266 Benicia Street Fremont, CA 94538 ITEM 2(a) NAME OF PERSON FILING: Orion Biomedical GP, LLC ("Orion GP") and Orion BioMedical Fund, LP ("Orion LP") ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 787 7th Avenue New York, NY 10019 ITEM 2(c). CITIZENSHIP: Orion GP is a Delaware limited liability company and Orion LP is a Delaware Limited Partnership. ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $0.001 par value. ITEM 2(e). CUSIP NUMBER: 14147M106 ITEM 3. |X| CHECK THIS BOX IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(c) ITEM 4(a). Ownership: Each of the Reporting Persons may be deemed the beneficial owner of the following number of Shares: Orion GP may be deemed to own 620,056 shares of Common Stock. These shares consist of 445,056 Shares owned by Orion LP and 175,000 Shares owned by Orion Biomedical Offshore Fund. ITEM 4(b). Percent of Class: The number of Shares of which each of Orion GP may be deemed to be the beneficial owner constitutes approximately 1.2% of the total number of Shares outstanding. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Orion GP and Orion LP no longer owns greater than 5% of any class of securities of the issuer. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable. 4 ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not Applicable ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in a transaction having that purpose and effect. SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 14, 2003 New York, New York /s/ Lindsay A. Rosenwald ---------------------------------------- Lindsay A. Rosenwald, M.D. Managing Member Orion Biomedical GP, LLC Dated: February 14, 2003 New York, New York /s/ Lindsay A. Rosenwald ---------------------------------------- Lindsay A. Rosenwald, M.D. Managing Member Orion Biomedical GP, LLC General Partner to Orion Biomedical Fund, L.P. 5 -----END PRIVACY-ENHANCED MESSAGE-----